Cite
HARVARD Citation
Amstutz, U. et al. (2018). Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update. Clinical pharmacology & therapeutics. 103 (2), pp. 210-216. [Online].